PMCID: PMC10520675
Fatigue or drowsiness: Some patients feel increased sleepiness at bedtime, which most consider a benefit rather than a side effect
Potential Side Effects and Limited Human Data While preclinical studies have not shown significant toxicity at standard doses, the research in humans is still in its early stages
Common reasons include the peptide not matching your main goal, the dose or schedule needing adjustment, the timeline being too short, poor sleep, inconsistent nutrition, high stress, alcohol use, hormone imbalance, thyroid dysfunction, blood sugar issues, or inflammation that has not been addressed
Opitac is a pharmaceutical-grade reduced L-glutathione manufactured by KOHJIN Life Sciences in Japan under strict quality control standards, clinically tested for purity, potency, and safety